During the past decade, Intensive Care Unit, Theageneio Oncological Hospital of Thessaloniki conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Intensive Care Unit, Theageneio Oncological Hospital of Thessaloniki" are "COVID-19" (1 trials), "Corona Virus Infection" (1 trials), "Macrophage Activation Syndrome" (1 trials), "Sepsis" (1 trials) and "Virus Diseases" (1 trials). Many other conditions were trialed in "Intensive Care Unit, Theageneio Oncological Hospital of Thessaloniki" in a lesser frequency.

Most popular intervention types in "Intensive Care Unit, Theageneio Oncological Hospital of Thessaloniki" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Anakinra" (1 trials), "Anakinra or rhIFNγ" (1 trials), "Placebo" (1 trials) and "Tocilizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Intensive Care Unit, Theageneio Oncological Hospital of Thessaloniki" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Intensive Care Unit, Theageneio Oncological Hospital of Thessaloniki". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Intensive Care Unit, Theageneio Oncological Hospital of Thessaloniki, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Intensive Care Unit, Theageneio Oncological Hospital of Thessaloniki, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".